1059 related articles for article (PubMed ID: 17710073)
1. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
2. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
Lanas A; Scheiman J
Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
[TBL] [Abstract][Full Text] [Related]
3. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
Johnson DA
Rev Cardiovasc Med; 2005; 6 Suppl 4():S15-22. PubMed ID: 17710072
[TBL] [Abstract][Full Text] [Related]
4. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
5. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Lanas A; Ferrandez A
Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
[TBL] [Abstract][Full Text] [Related]
6. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
7. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
Bretagne JF
Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
Laine L
Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
[TBL] [Abstract][Full Text] [Related]
9. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
10. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
Lanas A; Hunt R
Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
[TBL] [Abstract][Full Text] [Related]
11. NSAIDs-induced gastrointestinal damage. Review.
Arroyo M; Lanas A
Minerva Gastroenterol Dietol; 2006 Sep; 52(3):249-59. PubMed ID: 16971869
[TBL] [Abstract][Full Text] [Related]
12. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
[TBL] [Abstract][Full Text] [Related]
13. Drug-related damage of the ageing gastrointestinal tract.
Sostres C; Gargallo C; Lanas A
Best Pract Res Clin Gastroenterol; 2009; 23(6):849-60. PubMed ID: 19942163
[TBL] [Abstract][Full Text] [Related]
14. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
Rostom A; Moayyedi P; Hunt R;
Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
[TBL] [Abstract][Full Text] [Related]
15. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
16. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
17. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
19. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
Lanas A
Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
